Skip to main content

Month: June 2021

Clover Health to Scale In-home Primary Care Program Through Direct Contracting

Program has driven reductions in hospital stays and medical expensesInks new partnerships with leading home-based care providers, Spiras Health and Upward Health NASHVILLE, Tenn., June 09, 2021 (GLOBE NEWSWIRE) — Today, Clover Health (Nasdaq: CLOV) (“Clover”), an innovative technology company committed to improving health equity for America’s underserved seniors, announces plans to scale its in-home primary care program, Clover Home Care, through the U.S. Centers for Medicare and Medicaid Services’ (CMS) new Direct Contracting model. The goal of Direct Contracting is to make the Medicare program more financially sustainable for taxpayers while improving health outcomes for beneficiaries, which aligns with the work of Clover Home Care. Clover Home Care is led by Dr. Kumar Dharmarajan, Associate Chief Medical Officer of Clover and...

Continue reading

Hepion Pharmaceuticals to be Added to the Russell Microcap® Index

EDISON, N.J., June 09, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and liver disease, is pleased to announce that it is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, according to a preliminary list of additions posted June 4. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “Being...

Continue reading

Aleafia Health Establishes At-the-Market Equity Program

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has established an at-the-market equity program (the “ATM Program”). The ATM Program allows the Company to issue and sell, at its discretion, up to $30,000,000 of common shares in the capital of the Company (the “Common Shares”) to the public from time to time through Cantor Fitzgerald Canada Corporation (the “Agent”), as sole agent, at the prevailing market price when issued, directly on the Toronto Stock Exchange or any other recognized marketplace upon which the Common Shares are listed or quoted or where the Common Shares are traded in Canada. The ATM Program will be effective...

Continue reading

Visionstate’s Distribution Partner Bunzl Canada Collaborates with Tork to Upgrade WANDA IoT Solution Rolled Out at Queen’s University, Ontario

EDMONTON, Alberta, June 09, 2021 (GLOBE NEWSWIRE) — Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), a company that develops, and invests in the research and development of, promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability, is pleased to announce that its distribution partner, Bunzl Canada, a division of Bunzl Distribution USA, LLC, has partnered with Tork®, a leading global health and hygiene company, to integrate Visionstate’s WANDA™ facility management solution (labelled as wandaNEXT™ by Bunzl Canada) and Tork’s smart dispenser data into Bunzl’s digital cleaning program at Queen’s University in Kingston, Ontario. wandaNEXT™, developed by Visionstate IoT and now in partnership with Bunzl, is a cleaning program management system with multiple IoT sensor-enabled...

Continue reading

New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern

Adaptive’s immunoSEQ T-MAP COVID provides potential explanation for preservation of Johnson & Johnson vaccine (Ad26.COV2.S) response to variants even when neutralizing antibodies are diminished SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that immunoSEQ® T-MAP™ COVID was used in the Nature study to measure the T-cell immune response elicited by the Johnson & Johnson COVID-19 vaccine in the context of multiple variants of SARS-CoV-2, including B 1.351 and B.1.1.7. The study provides further evidence that the T-cell response may contribute to protection from COVID-19. Adaptive’s Technology was used...

Continue reading

KemPharm to be Added to Russell 2000® and Russell 3000® Indexes Effective June 28, 2021

CELEBRATION, Fla., June 09, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its expected addition to the broad-market Russell 3000® Index and the Russell 2000® Index in accordance with the 2021 Russell indexes annual reconstitution.  KemPharm’s anticipated inclusion in the Russell indexes will be effective after the U.S. market opens on Monday, June 28, 2021. “The expected addition of KemPharm to the Russell indexes is the latest milestone during what has been a truly transformational year for the Company. In just the last six months, we have received FDA approval for our lead drug candidate AZSTARYS™, completed a series of financial transactions that allowed KemPharm to up-list our stock to The Nasdaq...

Continue reading

VitalHub Announces Sale to University Hospitals Coventry and Warwickshire NHS Trust

TORONTO, June 09, 2021 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the recent sale of subsidiary Intouch with Health’s (“Intouch”) digital health platform to University Hospitals Coventry and Warwickshire NHS Trust (the “Trust” or “Coventry and Warwickshire”) and an expansion sale following a successful proof-of-concept installation. Coventry and Warwickshire is one of the UK’s largest teaching Trusts and is responsible for managing two major hospitals in Coventry and Rugby, serving a population of over 1 million people and providing more than 800,000 episodes of care to patients. The Trust principal teaching hospital for Warwick Medical School, with whom it works in close partnership with to develop innovative medical education programmes and clinical research. The Trust...

Continue reading

Adamis Provides Update on ZIMHI™

FDA Deems New Drug Application for ZIMHI Complete and Establishes a Target Action Date of November 12, 2021 SAN DIEGO, June 09, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s resubmitted New Drug Application (NDA) for ZIMHI™, which is its higher naloxone injection product candidate for the treatment of opioid overdose. Adamis received FDA correspondence relating to the Company’s NDA, stating that the Agency had completed its filing review and had determined that the NDA was sufficiently complete to permit a substantive review. The FDA also provided a target action date under the Prescription Drug User Fee Act (PDUFA date) of November 12, 2021. “We are pleased with the FDA’s decision to accept for review...

Continue reading

US Energy Initiatives Examines Multiple Opportunities Including a Gold and Silver Opportunity

WOODLAND HILLS, CA, June 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — US Energy Initiatives Corp, Inc. (OTC PINK:USEI) is pleased to announce that management has been investigating a number of business ventures that can bring significant shareholder value to the stockholders of the company. Management also invites shareholders to review an interview done this week with the company’s CEO that is informative @ https://recordings.tapeacall.com/t/heCIZr_MEpKA According to Anthony K. Miller, CEO, “Over the course of the last two months management has been investigating opportunities that it feels will become significant ventures for the company, and the most notable is a project in the gold and silver mining industry (obviously we will explain the deal better once we get closer to a close). Management is planning to leverage...

Continue reading

Reyna Silver Quadruples Claim Package at Medicine Springs and Announces 2021 Exploration Program Underway

Figure 1Medicine Springs Joint Venture Mineral ClaimsVANCOUVER, British Columbia and HONG KONG, June 09, 2021 (GLOBE NEWSWIRE) — Reyna Silver Corp. (TSXV: RSLV; OTCQB: RSNVF; FRA: 4ZC) (“Reyna”) announces that it has added 450 unpatented Federal mineral claims covering 3,642 hectares to its Medicine Springs Property located in the Ruby Mountains Valley in Elko County, Nevada. Medicine Springs shows many of the earmarks of a significant Carbonate Replacement Deposit (CRD) similar to the Santa Eulalia District in Chihuahua Mexico which hosts Reyna’s Guigui Project. Combined with the original 149 claims (1,189 ha) optioned from Northern Lights Resources Corp. (CSE: NLR) in 2020 (see press release of October 5, 2020) the property now consists of 599 contiguous claims covering 4,831 hectares, which covers the expanded...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.